This is an upcoming trial to study the effect of a botensilimab and balstilimab regimen in CRC patients with MRD after completing definitive standard-of-care therapy.
EMPIRE: Cemiplimab, Fianlimab, and REGN7075
Kathryn Aziz2025-09-22T20:11:16+00:00This is a study to determine if using immunotherapies alone or in combination with other drugs will delay or prevent colorectal cancer from coming back in patients with colorectal cancer who are ctDNA-positive after their treatment.